CompletedNot Applicable

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

Pakistan90 participantsStarted 2025-09-01

Plain-language summary

Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited. Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants of both genders were included if they were aged 30-60 years, * body mass index (BMI) ≥30 kg/m², * Individuals with HbA1c levels ranging from 5.7% to 10% were selected, .indicating pre-diabetic to diabetic status. Participants were required to have a .body mass index (BMI) of 25 kg/m² or higher Exclusion Criteria: * Participants who were diagnosed with type 1, pregnant or lactating, * chronic liver, kidney, or cardiovascular disease, * history of hepatotoxicity or gastrointestinal disorders, * using weight-loss supplements, steroids, or lipid-lowering drugs, or had a known allergy to Garcinia cambogia

What they're measuring

Weight

Timeframe: 12 weeks

Trial details

NCT IDNCT07419074

SponsorUniversity of Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-24

View on ClinicalTrials.gov More Lipid Profile trials